Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Malignant Melanoma

Free Subscription 19.05.2025 3 Ann Surg Oncol 1 Br J Dermatol 1 J Clin Invest 1 J Invest Dermatol 1 Nat Rev Cancer

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. RHODIN KE, O'Connor MH, Therien A, Hollander S, et al
   ASO Visual Abstract: Circulating Tumor DNA in High-Risk Stage II/III Cutaneous Melanoma: A Feasibility Study.
   Ann Surg Oncol. 2025 May 11. doi: 10.1245/s10434-025-17411.
   PubMed        
   
   
2. DUGAN MM, Boby A, Ghali H, Aflatooni S, et al
   Isolated Limb Infusion or Perfusion as First-Line Versus Second-Line Therapy for In-Transit Metastatic Melanoma.
   Ann Surg Oncol. 2025 May 10. doi: 10.1245/s10434-025-17403.
   PubMed         Abstract available
   
   
3. DUGAN MM, Beekman KE, Zager JS
   ASO Author Reflections: Successful Radar-Guided Localization for Targeted Melanoma Metastasectomy After Neoadjuvant Immunotherapy.
   Ann Surg Oncol. 2025 May 9. doi: 10.1245/s10434-025-17427.
   PubMed        
   
   

   
   Br J Dermatol

4. WANG Y, Xu G, Xia H
   Targeting the MAPK Pathway for NRAS Mutant Melanoma: From Mechanism to Clinic.
   Br J Dermatol. 2025 May 9:ljaf178. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Clin Invest

5. WANG Y, Ohnuki H, Tran AD, Wang D, et al
   Induced clustering of SHP2-depleted tumor cells in vascular islands restores sensitivity to MEK/ERK inhibition.
   J Clin Invest. 2025;135:e181609.
   PubMed         Abstract available
   
   

   
   J Invest Dermatol

6. POLO-SILVEIRA L, Dusza SW, Kentley J, Marchetti MA, et al
   Cutaneous Melanoma Risk Assessment Among Individuals with a High-Risk Nevus Phenotype.
   J Invest Dermatol. 2025 May 13:S0022-202X(25)00478.
   PubMed        
   
   

   
   Nat Rev Cancer

7. BREWER G
   Ageing lipids map melanoma's journey.
   Nat Rev Cancer. 2025 May 15. doi: 10.1038/s41568-025-00833.
   PubMed        
   
   

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.